Full Description
In this publication a comprehensive overview of the state of the art and future perspectives is given in the fields of basic research, diagnosis, therapy, suicide and relapse prevention, and psychiatric care regarding patients with affective disorders. Presented are decisive new developments which have been milestones in basic research or diagnosis, pharmacotherapy and psychotherapy of affective disorders. The contributions of renowned experts in the field include quantitative brain morphology and developments in genetics and neurochemistry. Special attention has been given to neuropharmacology, pharmacogenetics, electrophysiology, structural and functional neuroimaging of affective disorders as well as new therapeutic options in the field of psychotherapy. Moreover, important clinical issues such as modern aspects of preventing relapse, suicide and postnatal depression in mothers are discussed. Psychiatrists, psychotherapists, neurobiologists and students who participate in the treatment of patients with affective diseases will find this book valuable reading.
Contents
Psychiatric care with regard to depressed patients: historical comments on the foundation of the Weissenau depression unit, G. Hole; inpatient treatment of depression - the significance of special units for patients with depressive diseases, survey, conception and current state of experience, M. Wolfersdorf; screening and utilization of treatment in mothers with postnatal depression, C.-L. von Ballestrem, M. Strauss, H. Kachele. Basic research in affective disorders: genetics of mood disorders - current status of knowledge and prospects, W. Maier; functional neuro-imaging of depression, S. Erik, H. Walter, M. Spitzer; affective disorders and alterations of cardiac autonomic nervous system control. Therapeutic perspectives in affective disorders: new antidepressants in comparison with classical tricyclics - mechanisms of action and clinical evaluation, A. Broocks, K. Junghanns, A. Thiel, C.H. Gleiter, B. Bandelow; therapy with antidepressants - pharmacogenetic aspects, P. Baumann, D.F. Zullino; E. Jaquenoud Sirot, E. Paus; C.B. Eap; molecular mechanisms of action of mood stabilizers in bipolar disorder, D. van Calker; anti-suicidal effect of lithium as a criterion for the selection of appropriate long-term medication in bipolar patients, A. Bergohfer, M. Bauer, B. Muller-Oerlinghausen; mechanisms and management of weight gain associated with drug treatment of affective disorders, U. Zimmerman, T. Kraus, T. Pollmacher; electromagnetic stimulation and affective disorders, K.P. Ebmeier, J.M. Lappin; cyclothermic but not depressive temperament influences the mood of another person in social interactions, M. Hautzinger, T.D. Meyer, Pheasant, B.L.; pathological crying - modern treatment options, W.P. Kaschka, A. Meyer, K.R. Froscher.
